Research confirmed by the FDA suggests the use of the diabetes drug Invokana can increase the risk of lower limb amputations. Now, a more recent study suggests that the risk of amputations may extend to other diabetes drugs in the same class, including Jardiance and... Read More

A complaint was filed in late July alleging that the side effects of diabetes drug Invokana caused a Texas patient to undergo a double amputation of his legs below the knee, and to develop diabetic ketoacidosis and kidney failure. Product Liability Alleged in Invokana Lawsuit... Read More

In mid-May, a Louisiana man filed suit claiming that the side effects of Invokana (canagliflozin) resulted in a series of sores and infections that ultimately led to his left foot being amputated. The suit charges Invokana’s manufacturers, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals,... Read More

In early January, the number of Invokana claims pending in the Federal multidistrict litigation (MDL) rose higher than 1,000. The claims allege that Invokana caused patients prescribed it for treatment of diabetes to develop diabetic ketoacidosis, kidney failure and other injuries, and to undergo amputations.... Read More

An Iowa man is suing Johnson & Johnson and its subsidiary Janssen, claiming the defendants failed to adequately warn about Invokana side effects, which purportedly resulted in a partial leg amputation. According to the complaint, brought on December 13, 2017 in New Jersey Superior Court,... Read More

A wrongful death lawsuit was filed in mid September by the family of a Tennessee woman who was prescribed Farxiga for type 2 diabetes, alleging that side effects of the diabetes medication caused the kidney failure that killed her. Farxiga Side Effects Said to Cause... Read More

In mid-March, a joint lawsuit was filed against the manufacturers of Invokana alleging that the side effects of the drug caused diabetic ketoacidosis and kidney failure. The suit also alleges that the manufacturers, Johnson & Johnson and its subsidiary Janssen, failed to warn both patients and... Read More

In early February, plaintiffs in product liability cases involving the drug Farxiga (dapagliflozin) requested that all cases filed with federal court system over the side effects of the drug be moved to multidistrict litigation (MDL) in the U.S. District Court of the Eastern District of Pennsylvania.... Read More